KNW Stock Price, Know Labs, Inc. Quote, Chart

Market Summary

USD0.65+0.03

Delayed

4.84%

KNW Stock Price

View Fullscreen

KNW RSI Chart

KNW Valuation

Market Cap

52.9M

Price/Earnings (Trailing)

-3.55

Price/Sales (Trailing)

9.33

EV/EBITDA

-3.32

Price/Free Cashflow

-4.7

KNW Price/Sales (Trailing)

KNW Profitability

Operating Margin

100.00%

EBT Margin

-342.03%

Return on Equity

-1.2K%

Return on Assets

-297.48%

Free Cashflow Yield

-21.29%

KNW Fundamentals

KNW Revenue

Revenue (TTM)

4.4M

KNW Earnings

Earnings (TTM)

-14.9M

Earnings Growth (Yr)

9.84%

Earnings Growth (Qtr)

-17.38%

Breaking Down KNW Revenue

Last 7 days

16.1%

Last 30 days

1.6%

Last 90 days

62.5%

How does KNW drawdown profile look like?

KNW Financial Health

Current Ratio

1.27

KNW Investor Care

Shares Dilution (1Y)

68.74%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	0	0	0	0
2022	2.8M	3.6M	4.4M	0
2021	0	0	0	2.0M
2020	731.0K	349.7K	1.2M	0
2019	3.2M	2.4M	1.8M	1.3M
2018	4.6M	4.6M	4.3M	3.7M
2017	5.9M	5.1M	4.9M	5.0M
2016	5.8M	6.1M	6.0M	5.9M
2015	7.4M	6.9M	6.3M	5.7M
2014	8.2M	8.2M	8.0M	7.9M
2013	8.5M	8.7M	8.6M	8.4M
2012	7.9M	7.6M	7.9M	8.2M
2011	5.8M	7.5M	9.1M	8.9M
2010	0	0	2.5M	4.2M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Know Labs, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Feb 08, 2024	owens william arthur	acquired	49,000	0.49	100,000	-
Feb 08, 2024	pepper jon	acquired	49,000	0.49	100,000	-
Feb 08, 2024	cronin john e	acquired	7,920	0.49	16,164	-
Feb 08, 2024	takesako ichiro john paul	acquired	49,000	0.49	100,000	-
Feb 08, 2024	ellingson larry k	acquired	7,920	0.49	16,164	-
Feb 08, 2024	londergan timothy m	acquired	7,920	0.49	16,164	-
Oct 12, 2023	owens william arthur	acquired	8,750	0.25	35,000	-
Oct 12, 2023	pepper jon	acquired	8,750	0.25	35,000	-
Oct 12, 2023	takesako ichiro john paul	acquired	8,750	0.25	35,000	-

Which funds bought or sold KNW recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 22, 2024	PFG Investments, LLC	new	-	113,386	113,386	0.01%
Apr 17, 2024	Foguth Wealth Management, LLC.	new	-	60,348	60,348	0.03%
Apr 17, 2024	Fulcrum Capital LLC	added	2,249	190,613	197,401	0.05%
Apr 16, 2024	MCF Advisors LLC	unchanged	-	12.00	63.00	-%
Apr 10, 2024	Signal Advisors Wealth, LLC	reduced	-12.5	4,624	60,348	0.01%
Mar 11, 2024	VANGUARD GROUP INC	added	3.28	132,871	253,367	-%
Feb 15, 2024	Farther Finance Advisors, LLC	new	-	1,018	1,018	-%
Feb 14, 2024	CLEAR STREET LLC	new	-	20,000	20,000	-%
Feb 14, 2024	CITADEL ADVISORS LLC	new	-	76,860	76,860	-%
Feb 14, 2024	BRIDGEWAY CAPITAL MANAGEMENT, LLC	sold off	-100	-25,000	-	-%

Are Funds Buying or Selling KNW?

Are funds buying KNW calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own KNW

No. of Funds

Unveiling Know Labs, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Oct 26, 2023	baszucki todd	21.4%	17,200,000	SC 13D
Oct 19, 2023	erickson ronald p	1.9%	12,210,540	SC 13D/A

Recent SEC filings of Know Labs, Inc.

View All Filings

Date Filed	Form Type	Document
Apr 16, 2024	EFFECT	EFFECT
Apr 12, 2024	424B3	Prospectus Filed
Apr 09, 2024	S-1/A	Initial Public Offering
Mar 28, 2024	S-1	Initial Public Offering
Mar 20, 2024	424B5	Prospectus Filed
Mar 20, 2024	8-K	Current Report
Mar 06, 2024	8-K	Current Report
Mar 06, 2024	8-K/A	Current Report
Feb 29, 2024	8-K	Current Report
Feb 27, 2024	8-K	Current Report

Peers (Alternatives to Know Labs, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
AAPL	2.6T	385.7B	-2.32%	0.52%	25.91	6.78	-0.47%	6.03%
APH	72.3B	12.8B	4.50%	61.10%	35.48	5.63	1.52%	6.35%
FTV	26.7B	6.1B	-11.68%	19.45%	30.89	4.36	3.71%	14.65%
GLW	26.7B	12.6B	-5.15%	-4.37%	44.59	2.12	-11.28%	-55.18%
FLEX	12.2B	29.4B	1.19%	43.56%	16.2	0.42	-1.12%	-8.06%
MID-CAP
CGNX	7.0B	837.5M	-4.40%	-15.17%	61.55	8.32	-16.75%	-47.46%
ARW	6.9B	33.1B	-1.16%	14.50%	7.65	0.21	-10.82%	-36.63%
BMI	5.5B	740.8M	15.23%	39.67%	53.3	7.36	25.07%	42.99%
AVT	4.5B	25.6B	1.31%	23.33%	6.76	0.18	-2.73%	-21.96%
ESE	2.7B	968.8M	-0.54%	12.23%	29.23	2.81	9.35%	8.73%
SMALL-CAP
CNXN	1.7B	2.9B	-2.87%	59.27%	20.21	0.59	-8.78%	-6.67%
BHE	1.1B	2.8B	3.84%	47.53%	17.44	0.4	-1.64%	-5.74%
GPRO	263.8M	1.0B	-22.87%	-59.91%	-4.96	0.26	-8.05%	-284.36%
AEY	34.4M	56.7M	-10.16%	49.35%	-3.8	0.59	-41.04%	-726.48%
CPSH	25.7M	27.6M	-5.85%	-33.21%	18.75	0.93	3.62%	-35.71%

Know Labs, Inc. News

Latest updates

Know Labs, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3	2018Q2	2018Q1	2017Q4	2017Q3	2017Q2	2017Q1
Revenue	-	-	-	-	-	8,687	4,351,400	2,175,700	-	4,546	117,393	227,769	381,270	593,712	602,209	870,995	1,107,216	1,092,228	1,232,857	1,209,106	1,019,434	1,497,019
Cost Of Revenue	-	-	-	-	-	-	-	-	-	3,791	65,935	175,469	275,819	454,839	472,286	721,122	909,957	865,571	985,023	-	844,739	-
Gross Profit	-	-	-	-	-	-	-	-	-	755	51,458	52,300	105,451	138,873	129,923	149,873	197,259	226,657	247,834	238,154	174,695	304,545
Operating Expenses	-4.1%	3,497,634	3,648,122	5,836,213	3,025,453	2,851,436	5,221,059	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
S&GA Expenses	5.6%	2,011,246	1,905,071	3,864,140	1,588,823	1,448,227	1,216,947	1,666,754	634,169	1,622,941	920,551	1,799,710	689,027	1,003,504	689,446	712,527	803,857	578,097	-	-	-	-
R&D Expenses	-14.7%	1,486,388	1,743,051	1,978,590	1,272,537	1,248,707	885,752	720,180	375,243	447,165	491,138	425,317	441,541	184,024	206,990	203,705	125,789	153,300	-	-	-	-
EBITDA Margin	-43.0%	-3.32	-2.32	-2.69	-10.44	-22.31	-21.66	-20.66	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expenses	-100.0%	-	227,170	9,372	239,760	3,297,989	4,486,960	1,924,644	1,188,874	1,301,674	1,679,490	1,073,609	1,462,376	400,201	9,126	99,522	8,696	-	-	-	-	-
Income Taxes	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings Before Taxes	9.8%	-3,446,624	-3,822,859	-5,570,601	-3,003,286	-6,140,738	-5,356,619	-4,312,029	-2,905,086	-3,330,513	-3,015,013	-3,246,609	-2,154,266	-1,442,238	-769,203	-923,924	-506,254	-1,299,154	-	-	-	-
EBT Margin	19.6%	-3.42	-4.25	-4.60	-63.19	-74.88	-72.68	-38.78	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	9.8%	-3,446,624	-3,822,859	-5,570,601	-3,003,286	-6,140,738	-5,356,619	-4,312,029	-2,905,086	-3,330,513	-3,015,013	-3,246,609	-2,154,266	-1,442,238	-769,203	-923,924	-506,254	-1,299,154	-	-	-	-
Net Income Margin	19.6%	-3.42	-4.25	-4.60	-63.19	-74.88	-72.68	-38.78	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Free Cashflow	-16.3%	-3,405,344	-2,928,263	-3,240,433	-2,681,853	873,212	-1,920,403	-1,233,004	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Balance Sheet																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-39.4%	5,013	8,266	4,436	7,140	10,710	13,758	9,627	12,663	14,885	12,889	14,026	15,908	3,224	4,682	5,040	1,228	2,095	2,640	3,323	3,944	1,256
Current Assets	-39.9%	4,821	8,024	3,929	6,226	9,680	12,594	8,398	11,306	13,858	12,258	13,870	15,697	2,927	4,298	4,662	777	1,508	1,977	2,845	3,369	691
Cash Equivalents	-39.9%	4,821	8,024	3,929	6,226	9,680	12,594	8,352	11,187	10,734	12,258	13,870	15,697	2,927	4,298	4,662	777	1,502	1,901	2,689	3,062	311
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7.00	64.00	101	159
Net PPE	-7.4%	75.00	81.00	300	700	771	81.00	953	1,037	672	329	111	121	117	129	108	120	129	130	146	198	154
Current Liabilities	-16.2%	3,787	4,522	3,721	3,734	3,658	3,809	4,611	5,363	17,423	11,037	7,820	8,062	7,870	6,348	3,798	4,356	7,256	5,815	4,244	4,317	4,461
Shareholder's Equity	-67.3%	1,226	3,744	715	3,401	7,006	9,863	4,919	6,729	-	1,242	6,000	7,414	-	-	417	-	-	-	-	-	-
Retained Earnings	-2.9%	-125,351	-121,840	-118,715	-110,150	-105,220	-101,397	-95,827	-92,823	-86,683	-81,326	-73,730	-66,639	-61,265	-55,966	-51,654	-48,749	-45,418	-42,403	-39,157	-37,002	-35,560
Additional Paid-In Capital	0.8%	126,493	125,502	119,376	113,501	112,176	111,209	100,700	99,507	83,503	82,531	79,693	74,022	56,577	54,024	52,044	45,582	40,144	39,085	38,215	36,608	32,335
Shares Outstanding	1.2%	81,325	80,358	52,358	48,208	48,208	48,156	43,802	43,738	35,970	35,167	33,720	28,257	25,370	24,805	-	-	-	-	-	-	-
Float	-	-	-	-	32,310	-	-	-	70,531	-	-	-	64,103	-	-	-	13,419	-	-	-	17,689	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	-146.2%	-3,392	-1,377	-2,635	-3,423	-2,917	-3,228	-2,669	886	-1,907	-1,706	-1,897	-1,826	-1,421	-1,247	-977	-864	-824	-1,204	-751	-625	-522
Share Based Compensation	-	-	-	-	-	-	-	919	432	204	458	268	127	175	1,001	136	166	400	783	96.00	92.00	171
Cashflow From Investing	-1269800.0%	-12.70	1*	-38.94	-31.01	-10.85	-11.91	-16.60	-441	-385	-224	-39.59	-25.33	-9.63	-57.08	15.00	-12.38	-15.36	2*	-5.38	-71.71	-2.85
Cashflow From Financing	-96.3%	203	5,473	377	-	15.00	7,482	-149	9.00	769	346	83.00	14,621	60.00	941	4,849	151	441	417	384	3,448	-98.61

KNW Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
OPERATING EXPENSES-
RESEARCH AND DEVELOPMENT EXPENSES	$ 1,486,388	$ 1,743,051
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES	2,011,246	1,905,071
Total operating expenses	3,497,634	3,648,122
OPERATING LOSS	(3,497,634)	(3,648,122)
OTHER INCOME (EXPENSE), NET
Interest income	51,010	0
Interest expense	0	(227,170)
Other (expense) income, net	0	52,433
Total other income (expense), net	51,010	(174,737)
LOSS BEFORE INCOME TAXES	(3,446,624)	(3,822,859)
Income tax expense	0	0
NET LOSS	(3,446,624)	(3,822,859)
Deemed dividends on Series C and D Preferred Stock	(63,629)	0
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	$ (3,510,253)	$ (3,822,859)
Basic and diluted loss per share	$ (0.04)	$ (0.08)
Weighted average shares of common stock outstanding- basic and diluted	81,094,007	48,187,339

KNW Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2023	Sep. 30, 2023
CURRENT ASSETS:
Cash and cash equivalents	$ 4,821,477	$ 8,023,716
Total current assets	4,821,477	8,023,716
PROPERTY AND EQUIPMENT, NET	75,298	81,325
OTHER ASSETS
Other assets	18,767	15,766
Operating lease right-of-use asset	97,567	145,090
TOTAL ASSETS	5,013,109	8,265,897
CURRENT LIABILITIES:
Accounts payable - trade	627,058	1,292,861
Accrued expenses	95,952	94,062
Accrued expenses - related parties	196,241	218,334
Convertible notes payable, net	2,761,931	2,761,931
Current portion of operating lease right-of-use liability	106,038	154,797
Total current liabilities	3,787,220	4,521,985
COMMITMENTS AND CONTINGENCIES (Note 11)	0	0
Preferred stock - $0.001 par value, 5,000,000 shares authorized, Series C and D shares issued and outstanding as follows:
Common stock - $0.001 par value, 200,000,000 shares authorized, 81,346,524 and 80,358,463 shares issued and outstanding at 12/31/2023 and 9/30/2023, respectively	81,347	80,358
Additional paid in capital	126,492,778	125,501,537
Accumulated deficit	(125,351,041)	(121,840,788)
Total stockholders' equity	1,225,889	3,743,912
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	5,013,109	8,265,897
Convertible Preferred Stock Series C [Member]
Preferred stock - $0.001 par value, 5,000,000 shares authorized, Series C and D shares issued and outstanding as follows:
Preferred stock, value	1,790	1,790
Convertible Preferred Stocks Series D [Member]
Preferred stock - $0.001 par value, 5,000,000 shares authorized, Series C and D shares issued and outstanding as follows:
Preferred stock, value	$ 1,015	$ 1,015

About Know Labs, Inc.

Know Labs, Inc. focuses on the development and commercialization of proprietary biosensor technologies in the United States. Its proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy along the electromagnetic spectrum to perform analytics. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is based in Seattle, Washington.

CEO	Mr. Ronald P. Erickson J.D.
WEBSITE	knowlabs.co
INDUSTRY	Consumer Electronics
EMPLOYEES	11

Know Labs, Inc. Frequently Asked Questions

What is the ticker symbol for Know Labs, Inc.? What does KNW stand for in stocks?

KNW is the stock ticker symbol of Know Labs, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Know Labs, Inc. (KNW)?

As of Fri Apr 26 2024, market cap of Know Labs, Inc. is 52.88 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of KNW stock?

You can check KNW's fair value in chart for subscribers.

What is the fair value of KNW stock?

You can check KNW's fair value in chart for subscribers. The fair value of Know Labs, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Know Labs, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for KNW so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Know Labs, Inc. a good stock to buy?

The fair value guage provides a quick view whether KNW is over valued or under valued. Whether Know Labs, Inc. is cheap or expensive depends on the assumptions which impact Know Labs, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for KNW.

What is Know Labs, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 26 2024, KNW's PE ratio (Price to Earnings) is -3.55 and Price to Sales (PS) ratio is 9.33. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. KNW PE ratio will change depending on the future growth rate expectations of investors.